Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 May;37(5):1206. doi: 10.1128/aac.37.5.1206

Antimicrobial susceptibility of Capnocytophaga spp.

A Verghese, B Franzus, S Berk, D L Roscoe, A M Clarke
PMCID: PMC187936  PMID: 8517718

Full text

PDF

Page 1206

1206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bremmelgaard A., Pers C., Kristiansen J. E., Korner B., Heltberg O., Frederiksen W. Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria. APMIS. 1989 Jan;97(1):43–48. doi: 10.1111/j.1699-0463.1989.tb00753.x. [DOI] [PubMed] [Google Scholar]
  2. Hinrichs J. H., Dunkelberg W. E. DF-2 septicemia after splenectomy: epidemiology and immunologic response. South Med J. 1980 Dec;73(12):1638–1640. doi: 10.1097/00007611-198012000-00030. [DOI] [PubMed] [Google Scholar]
  3. Roscoe D. L., Zemcov S. J., Thornber D., Wise R., Clarke A. M. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother. 1992 Oct;36(10):2197–2200. doi: 10.1128/aac.36.10.2197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Schoen R. T., Wohlgelernter D., Barden G. E., Swartz T. J. Infection with CDC group DF-2 gram-negative rod: report of two cases. Arch Intern Med. 1980 May;140(5):657–658. [PubMed] [Google Scholar]
  5. Verghese A., Hamati F., Berk S., Franzus B., Berk S., Smith J. K. Susceptibility of dysgonic fermenter 2 to antimicrobial agents in vitro. Antimicrob Agents Chemother. 1988 Jan;32(1):78–80. doi: 10.1128/aac.32.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Waters M. J., Stern L., Andrew J. H. Dysgonic fermenter-2 septicemia. Pathology. 1986 Jan;18(1):162–164. doi: 10.3109/00313028609090848. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES